FDA Investigator Robert G Ruff

Robert G Ruff has inspections in 7 countries as of 20 Jul 2023. Robert G Ruff has collaborated with a combinined 3249 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
109
Last Inspection Date:
20 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
100004483
Country:
United Kingdom of Great Britain and Northern Ireland, United States of America, Canada, France, Denmark, Germany, Netherlands
Co-Investigator(s):
A Williams, Alberto A Viciedo, Allen Lou, Amy L Singer, Amy M Codella, Amy M Cramer, Amy S Graf, Ana S Cabrera, Annemarie Bodnar, Ashleigh P Wodushek, Barbara J Maulfair, Brian P Putz, Brian S Keefer, Bryan J Love, Byungja E Marciante, Calvin K Cook, Carl A Perez, Carolyn E Barney, Catherine J Laufmann, Charles J Chacko, Cherie T Parker, Cheryl G Scott, Christina N Maurino, Christine M Parmentier, Colin E Tack, Cynthia A Harris, MD, RN, Daniel L Aisen, Dannie E Rowland, Dave M Deroche, David H Smith, David J Gasparovich, David J Hafner, Dawn L Wydner, Debara R Reese, Deborah B Nixon, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Doreen P Canetti, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovace, Douglas C Kovacs, Edward O'shaughnessy, Edward Oshaughnessy, Edwin L Hobbs, Eileen A Liu, Elizabeth B Griffin, Elizabeth D Connell, Eric J Cunningham, Eric Rothschild, Eric S Pittman, Erin D Mccaffery, Esteban Beltran, Evelyn Taha, Frank J Marciniak, Gamal A Norton, George Pyramides, Gobiga Vanniyasingam, Gregson A Joseph, Harperd, Helen B Ricalde, Helen Verdel, Jacob M Dyer, Jacqueline S Warner, James A Beaulieu, James E Frye, James E Szelc, James H Tanner, James W Leonette, Jason M Sluzynski, Javonica F Penn, Jean Blackston Hill, Jean M Kelahan, Jeen S Min, Jeffrey J Ebersole, Jeffrey J, Ebersole, Jennifer L Custodio, Jesse A Vazquez, Jogy George, Jonathan Ho, Jonee J Mearns, Jose M Cayuela, Joseph F Mcginnis, RPh, Joy Rkozlowski Klena, Julianne C Mccullough, K Gonzlez, Karen A Coleman, Karen E D'orazio, Keith M Reilly, Kelli F Dobilas, Kelly Doremus, Kendra L Brooks, Kinh Q Mac, Kristen D Evans, Kristen E Rescigno, Kristina Mezin, Laiza V Garcia, Laureen M Geniusz, Lauren L Vajo, Leo J Lagrotte, Leonard H Lavi, Li Li, Lisa Harlan, Lisa Mathew, Loretta Nemchik, Lori S Lawless, Lydia S Chan, Marcelo O Mangalindan, Jr, Margaret M Sands, Maribeth G Grattan, Maribeth G Niesen, Marjorie D Schultz, Mary E Storch, Maryam Tabatabaie, Matthew A Spataro, Matthew R Noonan, Matthew W Kyle, Melanie W Pishnery, Melba T Rivera, Melba Trivera Clavell, Melissa A Freeman, Melissa A Zuppe, Michael J Nerz, Michael R Klapal, Michael Serrano, Michelle L Johnson, Miguel G Manzano, Miguel Gmanzano Maldonado, Minerva Rogers, Minh D Phan, Monica L Guitierrez, Monica L Gutierrez, Msdap Gonzlezk, Myra K Casey, Naakesh N Gomanie, Nancy L Neiger, Nikki S Ramirez, Patrick B Cummings, Pauline N Logan, Peter R Lenahan, Raffi B Papazian, Ralph Jerndal, Regina T Brown, Richard L Rutherford, Richard T Riggie, Ronald Ifraimov, Rosanna M Goodrich, Russell J Glapion, Ryan J Benedict, Sandra Kershaw, Sarah Forney, Sargum C Sood, Shannon A Gregory, Sherri J Liu, Sherry G Bous, Simone E Pitts, Sinai Davis, Stephanie T Durso, Stephen C Smith, Steven E Kane, Steven M Weinman, Steven S Wahl, Talmane J Fisher, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Teresa Jimenez, Teresa K Kastner, Thai T Duong, Thanh M Andrews, Thomas E Friel, Thomas J Arista, Timothy G Philips, Tressa T Lewis, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Vesa Vuniqi, Vlada Matusovsky, Wanda J Torres, Wei Wang, PhD, William D Bassett, Jr, William D Tingley, William R Brubaker, William R Chang, Xiuju Lu, Yung W Chan, Yvesna C Blaise, Zakaria I Ganiyu

Robert G Ruff's Documents

Publish Date Document Type Title
June, 2003 EIR Zoll Medical Corporation - EIR, 2003-06-03
June, 2003 FDA 483 Zoll Medical Corporation - Form 483, 2003-06-03
September, 2002 FDA 483 Response Cordis Corporation - Form 483R, 2002-09-27
March, 2002 EIR Datascope Corp. - EIR, 2002-03-01
May, 2000 FDA 483 Ethicon, Inc. - Form 483, 2000-05-24
April, 2003 FDA 483 Bipore Medical Devices, Inc. - Form 483, 2003-04-16
January, 2001 EIR Ethicon, Inc. - EIR, 2001-01-31
April, 2009 FDA 483 Maquet Cardiovascular, LLC - Form 483, 2009-04-17
May, 2000 EIR Ethicon, Inc. - EIR, 2000-05-30
August, 2010 FDA 483 Howmedica Osteonics Corp. d.b.a. Stryker Spine - Form 483, 2010-08-12
September, 2002 EIR Ethicon, Inc. - EIR, 2002-09-17
July, 2003 EIR Medtronic Sofamor Danek Deggendorf GmbH - EIR, 2003-07-17
October, 2000 FDA 483 Boston Scientific Corp. - Form 483, 2000-10-24
October, 2000 EIR Boston Scientific Corp. - EIR, 2000-10-24
March, 2001 FDA 483 Puretone Ltd. - Form 483, 2001-03-07
May, 2000 FDA 483 Response Ethicon, Inc. - Form 483R, 2000-06-06
September, 2004 FDA 483 DePuy Orthopaedics, Inc. - Form 483, 2004-09-21
June, 2010 FDA 483 Mindray DS USA, Inc. dba Mindray North America - Form 483, 2010-06-10
September, 2002 FDA 483 Ethicon, Inc. - Form 483, 2002-09-17
October, 2000 FDA 483 Response Boston Scientific Corp. - Form 483R, 2000-10-27
July, 2008 FDA 483 McNeil PPC Inc. - Form 483, 2008-07-31
January, 2003 EIR Independence Technology, LLC - EIR, 2003-01-31
December, 2002 EIR Isomedix Operations Inc. - EIR, 2002-12-18
April, 2003 EIR Bipore Medical Devices, Inc. - EIR, 2003-04-16
April, 2010 FDA 483 Datascope Corp. - Form 483, 2010-04-13
February, 2000 FDA 483 Exmoor Plastics - Form 483, 2000-02-03
September, 2002 EIR Cordis Corporation - EIR, 2002-09-11
July, 2008 EIR McNeil PPC Inc. - EIR, 2008-07-31
December, 2000 EIR Howmedica Osteonics Corp - EIR, 2000-12-19
April, 2009 EIR Maquet Cardiovascular, LLC - EIR, 2009-04-17
December, 2000 FDA 483 Howmedica Osteonics Corp - Form 483, 2000-12-19
June, 2009 FDA 483 Howmedica Osteonics Corp. - Form 483, 2009-06-19
April, 2003 FDA 483 Response Bipore Medical Devices, Inc. - Form 483R, 2003-04-29
October, 2000 FDA 483 Nexcore Technology, Inc. - Form 483, 2000-10-16
May, 2008 FDA 483 Ferring Pharmaceuticals Inc - Form 483, 2008-05-20
October, 2002 FDA 483 B.E.C. Manufacturing Corp. - Form 483, 2002-10-31
June, 2003 EIR Titan Implants, Inc - EIR, 2003-06-23
September, 2009 EIR Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - EIR, 2009-09-09

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more